Profile of ovarian cancer patients seeking information from a web-based decision support program

Journal of Women's Health
Maurie MarkmanJudith Petersen

Abstract

There is limited information available regarding the characteristics of patients who elect to gather and share information about their malignancy on the Internet. Using a proprietary decision support program embedded into a number of established websites, individuals entered personal clinical data into disease site profilers designed to provide information about evidence-based treatment options, based on specific characteristics (e.g., stage of disease, prior therapy) provided by the patients. The aggregate data were evaluated to examine the characteristics of patients with gynecological cancer (with a focus on newly diagnosed and recurrent ovarian cancer) using such a tool. From early 2000 through November 2004, >15,000 patients with gynecological cancer have entered data into one of four profilers: newly diagnosed (n = 5604)/recurrent (n = 2803) ovarian, endometrial, and cervical cancers. Internal data consistency includes similar ages and general health histories of the ovarian and endometrial cancer populations and younger age of the cervical cancer patients. Whereas 90% of the women with ovarian cancer considered themselves to be in "good health," 64% of newly diagnosed vs. only 50% of recurrent disease patients declared t...Continue Reading

References

Sep 14, 1995·The New England Journal of Medicine·J E MansonF E Speizer
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L M Glodé
Aug 29, 1996·The New England Journal of Medicine·P G Rose
Mar 8, 2000·The Oncologist·M Markman, M A Bookman
Apr 15, 2000·Nature·P G Kopelman
May 22, 2002·JAMA : the Journal of the American Medical Association·Gunther EysenbachEun-Ryoung Sa
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul R HelftChristopher K Daugherty
May 15, 2003·JAMA : the Journal of the American Medical Association·Laurence BakerM Kate Bundorf
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Sep 10, 2003·Hematology/oncology Clinics of North America·Maurie Markman
Jul 1, 2004·CA: a Cancer Journal for Clinicians·Gunther Eysenbach

❮ Previous
Next ❯

Citations

Sep 24, 2010·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Karen A StepanScott B Cantor
Nov 26, 2010·Journal of Health Communication·Bridget KellyNorman Wong
Dec 20, 2007·Computers, Informatics, Nursing : CIN·Eun-Ok ImWonshik Chee
Sep 1, 2009·Gynecologic Oncology·Talia FosterThomas J Herzog
Nov 7, 2008·Cancer Nursing·Mervi SiekkinenHelena Leino-Kilpi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Gynecologic Oncology
Vivian E von GruenigenSteven E Waggoner
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
L ChenC B Powell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Maurie MarkmanJerome Belinson
© 2022 Meta ULC. All rights reserved